DMD and Duchenne muscular dystrophy: The detection of dystrophin, which was absent in the myoblasts of DMD patients before DT-DEC01 administration, is particularly significant, as it proves that DEC cells provide functional dystrophin after administration to the DMD patients with the intent of restoring dystrophin in the DMD-affected muscles, thus addressing the primary cause of DMD [4].